NEW YORK, (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, visited the Nasdaq MarketSite in Times Square today in celebration of its initial public offering (IPO) on The Nasdaq Stock Market.
Source: NASDAQ